Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

NGM Biopharmaceuticals, Inc. NGM

Set alert

Price alert · NGM

All alert types
1.54 0.00 0.00%

At close · Apr 4

1.54 Day range 1.57

52-week range unavailable

Open
1.56
Prev close
1.54
Mkt cap
128.53M
Vol
2.21M
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
1.54
High
1.57
Forward P/E
-2.05
Beta
1.26
Short ratio
1.26
Inst. own
54.16%
Dividend
0.00
Ex-div date
Earnings
May 2, 2024
50-d avg
1.55
200-d avg
1.47
1y target
1.66

5D chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The five-day price history for NGM has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

-4.08 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -0.5×
FY 2016: -113×FY 2017: -56.5×FY 2018: -1934×FY 2019: -32.4×FY 2020: -22.1×FY 2021: -12.0×FY 2022: -2.5×FY 2023: -0.5×
FY 2016 5y median -12.0× FY 2023
P/S 16.0×
FY 2016: 9.2×FY 2017: 10.2×FY 2018: 8.8×FY 2019: 9.0×FY 2020: 23.7×FY 2021: 17.5×FY 2022: 7.3×FY 2023: 16.0×
FY 2016 5y median 16.0× FY 2023
P/B 0.5×
FY 2016: -6.9×FY 2017: -6.5×FY 2018: 5.1×FY 2019: 2.8×FY 2020: 7.4×FY 2021: 4.1×FY 2022: 1.5×FY 2023: 0.5×
FY 2016 5y median 2.8× FY 2023
P/FCF -0.5×
FY 2016: -33.5×FY 2017: -33.1×FY 2018: -71.1×FY 2019: -20.8×FY 2020: -24.3×FY 2021: -18.2×FY 2022: -2.7×FY 2023: -0.5×
FY 2016 5y median -18.2× FY 2023
EV/EBITDA -0.1×
FY 2016: -154×FY 2017: -69.5×FY 2018: 309×FY 2019: -13.9×FY 2020: -18.6×FY 2021: -10.1×FY 2022: -2.2×FY 2023: -0.1×
FY 2016 5y median -10.1× FY 2023
EV/Sales 2.7×
FY 2016: 8.7×FY 2017: 9.9×FY 2018: 8.3×FY 2019: 6.6×FY 2020: 22.1×FY 2021: 15.7×FY 2022: 6.0×FY 2023: 2.7×
FY 2016 5y median 6.6× FY 2023
FCF Yield -188.3%
FY 2016: -3.0%FY 2017: -3.0%FY 2018: -1.4%FY 2019: -4.8%FY 2020: -4.1%FY 2021: -5.5%FY 2022: -36.5%FY 2023: -188.3%
FY 2016 5y median -5.5% FY 2023

Profitability

Gross Margin 49.7%
FY 2016: 100.0%FY 2017: 100.0%FY 2018: 100.0%FY 2019: -24.8%FY 2020: -87.7%FY 2021: 89.9%FY 2022: 89.2%FY 2023: 49.7%
FY 2016 5y median 49.7% FY 2023
Operating Margin -3317.8%
FY 2016: -9.8%FY 2017: -22.6%FY 2018: -4.0%FY 2019: -47.7%FY 2020: -118.8%FY 2021: -155.0%FY 2022: -300.5%FY 2023: -3317.8%
FY 2016 5y median -155.0% FY 2023
Net Margin -3223.3%
FY 2016: -8.1%FY 2017: -18.4%FY 2018: -0.5%FY 2019: -27.5%FY 2020: -107.6%FY 2021: -146.2%FY 2022: -287.5%FY 2023: -3223.3%
FY 2016 5y median -146.2% FY 2023
ROE -95.8%
FY 2016: 6.0%FY 2017: 11.7%FY 2018: -0.3%FY 2019: -8.6%FY 2020: -33.6%FY 2021: -33.9%FY 2022: -61.3%FY 2023: -95.8%
FY 2016 5y median -33.9% FY 2023
ROIC -98.5%
FY 2016: -3.5%FY 2017: -7.6%FY 2018: -2.1%FY 2019: -9.6%FY 2020: -33.2%FY 2021: -33.0%FY 2022: -61.4%FY 2023: -98.5%
FY 2016 5y median -33.2% FY 2023
ROA -84.3%
FY 2016: -2.5%FY 2017: -5.7%FY 2018: -0.2%FY 2019: -7.5%FY 2020: -28.6%FY 2021: -28.3%FY 2022: -51.8%FY 2023: -84.3%
FY 2016 5y median -28.6% FY 2023

Growth (YoY)

Revenue -92.0%
FY 2016: 0.0%FY 2017: -9.9%FY 2018: 40.9%FY 2019: -4.7%FY 2020: -15.6%FY 2021: -10.9%FY 2022: -29.0%FY 2023: -92.0%
FY 2016 FY 2023
Operating Income 11.9%
FY 2016: 0.0%FY 2017: -108.4%FY 2018: 75.2%FY 2019: -1043.7%FY 2020: -110.4%FY 2021: -16.2%FY 2022: -37.7%FY 2023: 11.9%
FY 2016 FY 2023
EPS (diluted) 13.1%
FY 2016: 0.0%FY 2017: -100.0%FY 2018: 97.1%FY 2019: -7400.0%FY 2020: -140.4%FY 2021: -8.0%FY 2022: -34.5%FY 2023: 13.1%
FY 2016 FY 2023
Free Cash Flow 8.8%
FY 2016: 0.0%FY 2017: -1.3%FY 2018: 43.6%FY 2019: -232.3%FY 2020: -91.2%FY 2021: 12.3%FY 2022: -95.3%FY 2023: 8.8%
FY 2016 FY 2023

Financial Health

Current Ratio 7.8×
FY 2016: 6.2×FY 2017: 4.8×FY 2018: 5.2×FY 2019: 8.9×FY 2020: 7.2×FY 2021: 6.2×FY 2022: 6.0×FY 2023: 7.8×
FY 2016 5y median 7.2× FY 2023
Quick Ratio 7.8×
FY 2016: 6.2×FY 2017: 4.8×FY 2018: 5.2×FY 2019: 8.9×FY 2020: 7.2×FY 2021: 6.2×FY 2022: 6.0×FY 2023: 7.8×
FY 2016 5y median 7.2× FY 2023
Debt / Equity 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×
FY 2016 5y median 0.0× FY 2023
Net Debt / EBITDA 0.4×
FY 2016: 9.4×FY 2017: 2.3×FY 2018: -19.6×FY 2019: 5.0×FY 2020: 1.4×FY 2021: 1.2×FY 2022: 0.4×FY 2023: 0.4×
FY 2016 5y median 1.2× FY 2023
Interest Coverage 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: -44.8×FY 2023: 0.0×
FY 2016 5y median 0.0× FY 2023

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%
FY 2016 5y median 0.0% FY 2023
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%
FY 2016 5y median 0.0% FY 2023

Annual · latest fiscal year ends 2023-12-31